Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (6250)
All Articles published online
|
Publishing Process of This Article
|
Nov 14, 2014 (publication date) through Apr 28, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Montagnese S, Balistreri E, Schiff S, De Rui M, Angeli P, Zanus G, Cillo U, Bombonato G, Bolognesi M, Sacerdoti D, Gatta A, Merkel C, Amodio P. Covert hepatic encephalopathy: Agreement and predictive validity of different indices. World J Gastroenterol 2014; 20(42): 15756-15762 [PMID: 25400460 DOI: 10.3748/wjg.v20.i42.15756] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v20/i42/15756.htm |
| Number | Citing Articles |
| 1 |
Dieter Häussinger, Radha K. Dhiman, Vicente Felipo, Boris Görg, Rajiv Jalan, Gerald Kircheis, Manuela Merli, Sara Montagnese, Manuel Romero-Gomez, Alfons Schnitzler, Simon D. Taylor-Robinson, Hendrik Vilstrup. Hepatic encephalopathy. Nature Reviews Disease Primers 2022; 8(1) doi: 10.1038/s41572-022-00366-6
|
| 2 |
Harry D Zacharias, Fady Kamel, Jaclyn Tan, Nina Kimer, Lise Lotte Gluud, Marsha Y Morgan. Rifaximin for prevention and treatment of hepatic encephalopathy in people with cirrhosis. Cochrane Database of Systematic Reviews 2023; 2023(7) doi: 10.1002/14651858.CD011585.pub2
|
| 3 |
Paolo Feltracco, Annachiara Cagnin, Cristiana Carollo, Stefania Barbieri, Carlo Ori. Neurological disorders in liver transplant candidates: Pathophysiology and clinical assessment. Transplantation Reviews 2017; 31(3): 193 doi: 10.1016/j.trre.2017.02.006
|
| 4 |
Narayan Dharel, Jasmohan S. Bajaj. Definition and Nomenclature of Hepatic Encephalopathy. Journal of Clinical and Experimental Hepatology 2015; 5: S37 doi: 10.1016/j.jceh.2014.10.001
|
| 5 |
KASL clinical practice guidelines for liver cirrhosis: Varices, hepatic encephalopathy, and related complications. Clinical and Molecular Hepatology 2020; 26(2): 83 doi: 10.3350/cmh.2019.0010n
|
| 6 |
Christian Labenz, Larissa Beul, Gerrit Toenges, Jörn M. Schattenberg, Michael Nagel, Martin F. Sprinzl, Marc Nguyen-Tat, Tim Zimmermann, Yvonne Huber, Jens U. Marquardt, Peter R. Galle, Marcus-Alexander Wörns. Validation of the simplified Animal Naming Test as primary screening tool for the diagnosis of covert hepatic encephalopathy. European Journal of Internal Medicine 2019; 60: 96 doi: 10.1016/j.ejim.2018.08.008
|
| 7 |
Sara Montagnese, Michele De Rui, Paolo Angeli, Piero Amodio. Neuropsychiatric performance in patients with cirrhosis: Who is “normal”?. Journal of Hepatology 2017; 66(4): 825 doi: 10.1016/j.jhep.2016.11.021
|
| 8 |
Sara Montagnese, Mette Lauridsen, Hendrik Vilstrup, Lisa Zarantonello, Géza Lakner, Sergey Fitilev, Igor Zupanets, Irina Kozlova, Elena Bunkova, Krzysztof Tomasiewicz, Jan Erik Berglund, Fredrik Rorsman, Hannes Hagström, Stergios Kechagias, Carin Edmark Ocklind, Joe Mauney, Fredrik Thunarf, Masoud Mokhatarani, Torbjörn Bäckström, Magnus Doverskog, Lars-Erik Lins, Maria Månsson, Per Samuelson, Dag Nilsson, Martin Schalling, Maja Johansson, Eva Arlander, Bruce F. Scharschmidt. A pilot study of golexanolone, a new GABA-A receptor-modulating steroid antagonist, in patients with covert hepatic encephalopathy. Journal of Hepatology 2021; 75(1): 98 doi: 10.1016/j.jhep.2021.03.012
|
| 9 |
C. Labenz, J. S. Baron, G. Toenges, J. M. Schattenberg, M. Nagel, M. F. Sprinzl, M. Nguyen‐Tat, T. Zimmermann, Y. Huber, J. U. Marquardt, P. R. Galle, M.‐A. Wörns. Prospective evaluation of the impact of covert hepatic encephalopathy on quality of life and sleep in cirrhotic patients. Alimentary Pharmacology & Therapeutics 2018; 48(3): 313 doi: 10.1111/apt.14824
|
| 10 |
Cristina Ripoll. The advantage of calling things by the same name. Liver Transplantation 2018; 24(5): 581 doi: 10.1002/lt.25061
|
| 11 |
Francesco Vizzutti, Filippo Schepis, Umberto Arena, Fabrizio Fanelli, Stefano Gitto, Silvia Aspite, Laura Turco, Gabriele Dragoni, Giacomo Laffi, Fabio Marra. Transjugular intrahepatic portosystemic shunt (TIPS): current indications and strategies to improve the outcomes. Internal and Emergency Medicine 2020; 15(1): 37 doi: 10.1007/s11739-019-02252-8
|
| 12 |
Carla Giménez-Garzó, Juan José Garcés, Amparo Urios, Alba Mangas-Losada, Raquel García-García, Olga González-López, Remedios Giner-Durán, Desamparados Escudero-García, Miguel Angel Serra, Emilio Soria, Vicente Felipo, Carmina Montoliu, Han-Chieh Lin. The PHES battery does not detect all cirrhotic patients with early neurological deficits, which are different in different patients. PLOS ONE 2017; 12(2): e0171211 doi: 10.1371/journal.pone.0171211
|
| 13 |
Richard Parker. Early identification of hepatic encephalopathy improves outcomes. British Journal of Nursing 2020; 29(Sup17): S10 doi: 10.12968/bjon.2020.29.Sup17.S10
|
| 14 |
Marsha Y. Morgan. Sherlock's Diseases of the Liver and Biliary System. 2018; : 151 doi: 10.1002/9781119237662.ch10
|
| 15 |
Simon Johannes Gairing, Chiara Mangini, Lisa Zarantonello, Stefania Gioia, Elise Jonasson Nielsen, Sven Danneberg, Anna S. Lok, Philippe Sultanik, Peter Robert Galle, Joachim Labenz, Dominique Thabut, Jens Uwe Marquardt, Patricia P. Bloom, Mette Munk Lauridsen, Sara Montagnese, Silvia Nardelli, Christian Labenz. Minimal hepatic encephalopathy is associated with a higher risk of overt hepatic encephalopathy and poorer survival. Journal of Internal Medicine 2024; 295(3): 331 doi: 10.1111/joim.13747
|
| 16 |
Marko Vojnovic, Ivana Pantic, Goran Jankovic, Milos Stulic, Milica Stojkovic Lalosevic, Nina Pejic, Tamara Milovanovic. EncephalApp Stroop Test as a Screening Tool for the Detection of Minimal Hepatic Encephalopathy in Patients with Cirrhosis—Single-Center Experience. Gastroenterology Insights 2024; 15(1): 237 doi: 10.3390/gastroent15010017
|
| 17 |
Alena F. Ehrenbauer, Julius F.M. Egge, Maria M. Gabriel, Anja Tiede, Meike Dirks, Jennifer Witt, Heiner Wedemeyer, Benjamin Maasoumy, Karin Weissenborn. Comparison of 6 tests for diagnosing minimal hepatic encephalopathy and predicting clinical outcome: A prospective, observational study. Hepatology 2024; doi: 10.1097/HEP.0000000000000770
|
| 18 |
Maja Johansson, Jessica Strömberg, Gianna Ragagnin, Magnus Doverskog, Torbjörn Bäckström. GABAA receptor modulating steroid antagonists (GAMSA) are functional in vivo. The Journal of Steroid Biochemistry and Molecular Biology 2016; 160: 98 doi: 10.1016/j.jsbmb.2015.10.019
|
| 19 |
Christopher F. Rose, Piero Amodio, Jasmohan S. Bajaj, Radha Krishan Dhiman, Sara Montagnese, Simon D. Taylor-Robinson, Hendrik Vilstrup, Rajiv Jalan. Hepatic encephalopathy: Novel insights into classification, pathophysiology and therapy. Journal of Hepatology 2020; 73(6): 1526 doi: 10.1016/j.jhep.2020.07.013
|
| 20 |
Mahmoud A Osman, Moataz M Sayed, Khaled A Mansour, Shereen A Saleh, Wesam A Ibrahim, Sara M Abdelhakam, Mohamed Bahaa, Wael A Yousry, Hosam S Elbaz, Reginia N Mikhail, Azza M Hassan, Ehab H Elsayed, Dalia A Mahmoud. Reversibility of minimal hepatic encephalopathy following liver transplantation in Egyptian cirrhotic patients. World Journal of Hepatology 2016; 8(30): 1279-1286 doi: 10.4254/wjh.v8.i30.1279
|
| 21 |
Karin Weissenborn. Hepatic Encephalopathy: Definition, Clinical Grading and Diagnostic Principles. Drugs 2019; 79(S1): 5 doi: 10.1007/s40265-018-1018-z
|
| 22 |
R. Greinert, A. Zipprich, C. Ripoll. Letter: stepwise diagnosis in covert hepatic encephalopathy – critical flicker frequency and MELD‐score as a first‐step approach. Replication and pitfalls. Authors‘ reply. Alimentary Pharmacology & Therapeutics 2017; 45(1): 189 doi: 10.1111/apt.13850
|
| 23 |
H. D. Zacharias, C. D. Jackson, M. Y. Morgan, S. S. Olesen. Letter: stepwise diagnosis in covert hepatic encephalopathy – critical flicker frequency and MELD‐score as a first‐step approach. Replication and pitfalls. Alimentary Pharmacology & Therapeutics 2017; 45(1): 187 doi: 10.1111/apt.13830
|
| 24 |
Leonard Kaps, Katharina Hildebrand, Michael Nagel, Maurice Michel, Wolfgang Maximilian Kremer, Max Hilscher, Peter R. Galle, Jörn M. Schattenberg, Marcus-Alexander Wörns, Christian Labenz. Validation of EncephalApp_Stroop as screening tool for the detection of minimal hepatic encephalopathy in German patients with liver cirrhosis. Clinics and Research in Hepatology and Gastroenterology 2022; 46(4): 101873 doi: 10.1016/j.clinre.2022.101873
|
| 25 |
Sara Montagnese, Francesco Paolo Russo, Piero Amodio, Patrizia Burra, Antonio Gasbarrini, Carmela Loguercio, Giulio Marchesini, Manuela Merli, Francesca Romana Ponziani, Oliviero Riggio, Carmelo Scarpignato. Hepatic encephalopathy 2018: A clinical practice guideline by the Italian Association for the Study of the Liver (AISF). Digestive and Liver Disease 2019; 51(2): 190 doi: 10.1016/j.dld.2018.11.035
|
| 26 |
Juan Miguel Abdo Francis, Mauricio de Ariño Suárez, Graciela Elia Castro Narro, René Malé Velázquez, Mayra Virginia Ramos Gómez, María Teresa Rizo Robles, José Antonio Velarde Ruiz Velasco. Encefalopatía hepática: historia natural de la enfermedad, nueva clasificación e impacto en la calidad de vida. Latin american journal of clinical sciences and medical technology 2019; 1(1): 50 doi: 10.34141/LJCS1419379
|
| 27 |
Karen Louise Thomsen, Jane Macnaughtan, Giovanni Tritto, Rajeshwar P. Mookerjee, Rajiv Jalan, Matias A Avila. Clinical and Pathophysiological Characteristics of Cirrhotic Patients with Grade 1 and Minimal Hepatic Encephalopathy. PLOS ONE 2016; 11(1): e0146076 doi: 10.1371/journal.pone.0146076
|
| 28 |
Carla Giménez-Garzó, Alessandra Fiorillo, María-Pilar Ballester-Ferré, Juan-José Gallego, Franc Casanova-Ferrer, Amparo Urios, Salvador Benlloch, David Martí-Aguado, Teresa San-Miguel, Joan Tosca, María-Pilar Ríos, Cristina Montón, Lucía Durbán, Desamparados Escudero-García, Luis Aparicio, Vicente Felipo, Carmina Montoliu. A New Score Unveils a High Prevalence of Mild Cognitive Impairment in Patients with Nonalcoholic Fatty Liver Disease. Journal of Clinical Medicine 2021; 10(13): 2806 doi: 10.3390/jcm10132806
|
| 29 |
Andy Liu, Ryan B Perumpail, Radhika Kumari, Zobair M Younossi, Robert J Wong, Aijaz Ahmed. Advances in cirrhosis: Optimizing the management of hepatic encephalopathy. World Journal of Hepatology 2015; 7(29): 2871-2879 doi: 10.4254/wjh.v7.i29.2871
|
| 30 |
B. Hermann, A. Santiago, S. Mouri, D. Thabut, N. Weiss. Nouveautés dans l’encéphalopathie hépatique : de l’encéphalopathie hépatique minimale à l’encéphalopathie hépatique clinique. Pratique Neurologique - FMC 2018; 9(1): 1 doi: 10.1016/j.praneu.2018.01.001
|
| 31 |
P. I. Kuznetsova, A. A. Raskurazhev, S. N. Morozova, I. M. Lovchev, M. S. Novruzbekov, M. M. Tanashyan. Minimal hepatic encephalopathy: clinical, neurophysiological, neuroimaging markers. Russian neurological journal 2023; 28(5): 21 doi: 10.30629/2658-7947-2023-28-5-21-27
|
| 32 |
Jessica Faccioli, Silvia Nardelli, Stefania Gioia, Oliviero Riggio, Lorenzo Ridola. Minimal Hepatic Encephalopathy Affects Daily Life of Cirrhotic Patients: A Viewpoint on Clinical Consequences and Therapeutic Opportunities. Journal of Clinical Medicine 2022; 11(23): 7246 doi: 10.3390/jcm11237246
|
| 33 |
Christopher R. Flud, Andres Duarte-Rojo. Prognostic Implications of Minimal/Covert Hepatic Encephalopathy: Large-scale Validation Cohort Studies. Journal of Clinical and Experimental Hepatology 2019; 9(1): 112 doi: 10.1016/j.jceh.2018.04.009
|
| 34 |
Lise L. Gluud, Rebecca Jeyaraj, Marsha Y. Morgan. Outcomes in Clinical Trials Evaluating Interventions for the Prevention and Treatment of Hepatic Encephalopathy. Journal of Clinical and Experimental Hepatology 2019; 9(3): 354 doi: 10.1016/j.jceh.2019.02.004
|
| 35 |
Harry D Zacharias, Antony P Zacharias, Lise Lotte Gluud, Marsha Y Morgan. Pharmacotherapies that specifically target ammonia for the prevention and treatment of hepatic encephalopathy in adults with cirrhosis. Cochrane Database of Systematic Reviews 2019; doi: 10.1002/14651858.CD012334.pub2
|
| 36 |
Anna Hadjihambi, Natalia Arias, Mohammed Sheikh, Rajiv Jalan. Hepatic encephalopathy: a critical current review. Hepatology International 2018; 12(S1): 135 doi: 10.1007/s12072-017-9812-3
|
| 37 |
Jasmohan S. Bajaj. Diagnosing Minimal Hepatic Encephalopathy: From the Ivory Tower to the Real World. Gastroenterology 2015; 149(6): 1330 doi: 10.1053/j.gastro.2015.09.028
|
| 38 |
Andres Duarte-Rojo, Sanath Allampati, Leroy R. Thacker, Christopher R. Flud, Kavish R. Patidar, Melanie B. White, Jagpal S. Klair, Douglas M. Heuman, James B. Wade, Edith A. Gavis, Jasmohan S. Bajaj. Diagnosis of covert hepatic encephalopathy: a multi-center study testing the utility of single versus combined testing. Metabolic Brain Disease 2019; 34(1): 289 doi: 10.1007/s11011-018-0350-z
|
| 39 |
Jasmohan S. Bajaj, Mette Lauridsen, Elliot B. Tapper, Andres Duarte-Rojo, Robert S. Rahimi, Puneeta Tandon, Debbie L. Shawcross, Dominique Thabut, Radha K. Dhiman, Manuel Romero-Gomez, Barjesh C. Sharma, Sara Montagnese. Important Unresolved Questions in the Management of Hepatic Encephalopathy: An ISHEN Consensus. American Journal of Gastroenterology 2020; 115(7): 989 doi: 10.14309/ajg.0000000000000603
|
| 40 |
Sanath Allampati, Andres Duarte-Rojo, Leroy R Thacker, Kavish R Patidar, Melanie B White, Jagpal S Klair, Binu John, Douglas M Heuman, James B Wade, Christopher Flud, Robert O’Shea, Edith A Gavis, Ariel B Unser, Jasmohan S Bajaj. Diagnosis of Minimal Hepatic Encephalopathy Using Stroop EncephalApp: A Multicenter US-Based, Norm-Based Study. American Journal of Gastroenterology 2016; 111(1): 78 doi: 10.1038/ajg.2015.377
|
| 41 |
B. Hermann, N. Weiss, D. Thabut. Letter: stepwise diagnosis in covert hepatic encephalopathy – do not forget ammonia. Alimentary Pharmacology & Therapeutics 2016; 44(8): 906 doi: 10.1111/apt.13760
|
| 42 |
An-Jiang Wang, A-Ping Peng, Bi-Min Li, Na Gan, Li Pei, Xue-Lian Zheng, Jun-Bo Hong, Hai-Ying Xiao, Jia-Wei Zhong, Xuan Zhu. Natural history of covert hepatic encephalopathy: An observational study of 366 cirrhotic patients. World Journal of Gastroenterology 2017; 23(34): 6321-6329 doi: 10.3748/wjg.v23.i34.6321
|
| 43 |
Elliot B. Tapper. Predicting Overt Hepatic Encephalopathy for the Population With Cirrhosis. Hepatology 2019; 70(1): 403 doi: 10.1002/hep.30533
|
| 44 |
D. Mladenović, D. Hrnčić, A. Rašić-Marković, Dj. Macut, O. Stanojlović. The Influence of Finasteride on Mean and Relative Spectral Density of EEG Bands in Rat Model of Thioacetamide-Induced Hepatic Encephalopathy. Neurotoxicity Research 2016; 30(2): 150 doi: 10.1007/s12640-016-9610-z
|
| 45 |
Jasmohan S. Bajaj, Andrew Fagan, Melanie B. White, James B. Wade, Phillip B. Hylemon, Douglas M. Heuman, Michael Fuchs, Binu V. John, Chathur Acharya, Masoumeh Sikaroodi, Patrick M. Gillevet. Specific Gut and Salivary Microbiota Patterns Are Linked With Different Cognitive Testing Strategies in Minimal Hepatic Encephalopathy. American Journal of Gastroenterology 2019; 114(7): 1080 doi: 10.14309/ajg.0000000000000102
|
| 46 |
Jasmohan S. Bajaj. Introduction and setting the scene: New nomenclature of hepatic encephalopathy and American Association for the Study of Liver Diseases/European Association for the Study of the Liver guidelines. Clinical Liver Disease 2017; 9(2): 48 doi: 10.1002/cld.610
|
| 47 |
Rodrigo C. Surjan, Elizabeth S. dos Santos, Tiago Basseres, Fabio F. Makdissi, Marcel A. Machado. A Proposed Physiopathological Pathway to Hyperammonemic Encephalopathy in a Non-Cirrhotic Patient with Fibrolamellar Hepatocellular Carcinoma without Ornithine Transcarbamylase (OTC) Mutation. American Journal of Case Reports 2017; 18: 234 doi: 10.12659/AJCR.901682
|